MB, Levis & Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
MB, Levis & Associates's AMGN Position: Q2 2026 in Review
MB, Levis & Associates reduced its Amgen (AMGN) stake by 0.95% in Q2 2026, selling an estimated $9.59K and leaving 2,928 shares worth $1.06M. The position accounts for 0.39% of the portfolio, ranked #35.
MB, Levis & Associates first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.2M in Q3 2024. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- MB, Levis & Associates held 2,928 shares of Amgen worth $1.06M as of Q2 2026.
- MB, Levis & Associates sold 28 Amgen shares in Q2 2026, an estimated $9.59K.
- Amgen made up 0.39% of MB, Levis & Associates's portfolio in Q2 2026, its #35 holding.
- MB, Levis & Associates first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
- MB, Levis & Associates's Amgen position peaked at $1.2M in Q3 2024.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.